The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Mechanisms of Bioactivities of Fucoidan from the Brown Seaweed Fucus vesiculosus L. of the Barents Sea
Open accessAbstract
The aim of this study was to elucidate some mechanisms of radical scavenging and the anti-inflammatory, anti-hyperglycemic, and anti-coagulant bioactivities of high molecular weight fucoidan from Fucus vesiculosus in several in vitro models. Fucoidan has displayed potent 1, 1-diphenyl-2-picryl hydrazil radical scavenging and reduction power activities. It significantly inhibits the cyclooxygenase-2 (COX-2) enzyme (IC50 4.3 μg mL−1) with a greater selectivity index (lg(IC80 COX-2/IC80COX-1), −1.55) than the synthetic non-steroidal anti-inflammatory drug indomethacin (lg(IC80 COX-2/IC80COX-1), −0.09). A concentration-dependent inhibition of hyaluronidase enzyme with an IC50 of 2.9 μg mL−1 was observed. Fucoidan attenuated the lipopolysaccharide-induced expression of mitogen-activated protein kinase p38. Our findings suggest that the inhibition of dipeptidyl peptidase-IV (DPP-IV) (IC50 1.11 μg mL−1) is one of the possible mechanisms involved in the anti-hyperglycemic activity of fucoidan. At a concentration of 3.2 μg mL−1, fucoidan prolongs the activated partial thromboplastin time and thrombin time by 1.5-fold and 2.5-fold compared with a control, respectively. A significant increase of prothrombin time was observed after the concentration of fucoidan was increased above 80 μg mL−1. This evidenced that fucoidan may have an effect on intrinsic/common pathways and little effect on the extrinsic mechanism. This study sheds light on the multiple pathways of the bioactivities of fucoidan. As far as we know, the inhibition of hyaluronidase and DPP-IV by high molecular fucoidan was studied for the first time in this work. Our results and literature data suggest that molecular weight, sulfate content, fucose content, and polyphenols may contribute to these activities. It seems that high molecular weight fucoidan has promising therapeutic applications in different pharmacological settings. Anti-oxidant, anti-inflammatory and anti-coagulant drugs have been used for the management of complications of COVID19. Taken as a whole, fucoidan could be considered as a prospective candidate for the treatment of patients with COVID19; however, additional research in this field is required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cyclooxygenases: Structural, cellular, and molecular biology
Smith, W. L., DeWitt, D. L., & Garavito, R. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.145 · Cited by 2,925 · cited 1×
“Moreover, COX-2 is not present under normal conditions, but is formed under the influence of some tissue factors initiating the inflammatory reaction [54,55].”
BackgroundZhang, W., Zhao, Y., Zhang, F., Wang, Q., Li, T., Liu, Z., Wang, J., Qin, Y., Zhang, X., Yan, X., et al. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108393 · Cited by 1,266
Ale, M. T., Mikkelsen, J. D., & Meyer, A. S. (2011) · Marine Drugs · doi:10.3390/md9102106 · Cited by 779
Wang, J., Zhang, Q., Zhang, Z., Song, H., & Li, P. (2010) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2009.10.015 · Cited by 456
Ale, M. T., & Meyer, A. S. (2013) · RSC Adv. · doi:10.1039/c3ra23373a · Cited by 381
Yuan, Y., & Macquarrie, D. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.04.057 · Cited by 371
Therapies from Fucoidan: New Developments
Fitton, J. H., Stringer, D. N., Park, A. Y., & Karpiniec, S. S. (2019) · Marine Drugs · doi:10.3390/md17100571 · Cited by 225
In vitro and in vivo hypoglycemic effects of brown algal fucoidans
Shan, X., Liu, X., Hao, J., Cai, C., Fan, F., Dun, Y., Zhao, X., Liu, X., Li, C., & Yu, G. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.11.036 · Cited by 166
Phull, A. R., & Kim, S. J. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.09.051 · Cited by 115
Asanka Sanjeewa, K. K., Jayawardena, T. U., Kim, H.-S., Kim, S.-Y., Shanura Fernando, I. P., Wang, L., Abetunga, D. T. U., Kim, W.-S., Lee, D.-S., & Jeon, Y.-J. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.115195 · Cited by 102
Research works printed but not linked: 68
- Mayer, A.M.S., Guerrero, A.J., Rodríguez, A.D., Taglialatela-Scafati, O., Nakamura, F., and Fusetani, N. (2020). Marine pharmacology in 2014–2015: Marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, antiviral, and anthelmintic activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action. Mar. Drugs, 18. · DOI
- Usov, 2009, Fucoidans—Sulfated polysaccharides of brown algae, Russ. Chem. Revs., 78, 785, 10.1070/RC2009v078n08ABEH004063 · DOI
- Ushakova, 2008, Anticoagulant activity of fucoidans from brown algae, Biomed. Khim., 54, 597
- Wang, 2008, Antioxidant activity of sulfated polysaccharide fractions extracted from Laminaria japonica, Int. J. Biol. Macromol., 42, 127, 10.1016/j.ijbiomac.2007.10.003 · DOI · Paper page
- Wang, Y., Xing, M., Cao, Q., Ji, A., Liang, H., and Song, S. (2019). Biological activities of fucoidan and the factors mediating its therapeutic effects: A review of recent studies. Mar. Drugs, 17. · DOI · Paper page
- Koh, 2019, Structure characterization and antioxidant activity of fucoidan isolated from Undaria pinnatifida grown in New Zealand, Carbohydr. Polym., 212, 178, 10.1016/j.carbpol.2019.02.040 · DOI · Paper page
- Fernando, 2018, Antioxidant and anti-inflammatory functionality of ten Sri Lankan seaweed extracts obtained by carbohydrase assisted extraction, Food Sci. Biotechnol., 27, 1761, 10.1007/s10068-018-0406-1 · DOI
- Yang, 2017, Inhibitory effect of fucoidan on hypoglycemia in diabetes mellitus anim, Int. J. Clin. Exp. Med., 10, 8529
- Fernando, 2020, Therapeutic potential of algal natural products against metabolic syndrome: A review of recent developments, Trends Food Sci. Technol., 97, 286, 10.1016/j.tifs.2020.01.020 · DOI
- Irhimeh, 2009, Pilot clinical study to evaluate the anticoagulant activity of fucoidan, Blood Coagul. Fibrinolysis, 20, 607, 10.1097/MBC.0b013e32833135fe · DOI
- Wang, 2011, In vitro anticoagulant activity of fucoidan derivatives from brown seaweed Laminaria japonica, Chin. J. Oceanol. Limnol., 29, 679, 10.1007/s00343-011-0181-9 · DOI
- Zhao, 2016, Antithrombotic activity of oral administered low molecular weight fucoidan from Laminaria japonica, Thromb. Res., 144, 46, 10.1016/j.thromres.2016.03.008 · DOI
- Krylova, N.V., Ermakova, S.P., Lavrov, V.F., Leneva, I.A., Kompanets, G.G., Iunikhina, O.V., Nosik, M.N., Ebralidze, L.K., Falynskova, I.N., and Silchenko, A.S. (2020). The comparative analysis of antiviral activity of native and modified fucoidans from brown algae Fucus evanescens in vitro and in vivo. Mar. Drugs, 18. · DOI
- Pozharitskaya, O.N., Shikov, A.N., Faustova, N.M., Obluchinskaya, E.D., Kosman, V.M., Vuorela, H., and Makarov, V.G. (2018). Pharmacokinetic and tissue distribution of fucoidan from Fucus vesiculosus after oral administration to rats. Mar. Drugs, 16. · DOI
- Oka, 2020, Properties of fucoidans beneficial to oral healthcare, Odontology, 108, 34, 10.1007/s10266-019-00437-3 · DOI
- Fitton, 2015, Topical benefits of two fucoidan-rich extracts from marine macroalgae, Cosmetics, 2, 66, 10.3390/cosmetics2020066 · DOI
- Chakraborty, 2016, Characterization of substituted aryl meroterpenoids from red seaweed Hypnea musciformis as potential antioxidants, Food Chem., 212, 778, 10.1016/j.foodchem.2016.06.039 · DOI
- Zhang, 2015, Antioxidant phytochemicals for the prevention and treatment of chronic diseases, Molecules, 20, 21138, 10.3390/molecules201219753 · DOI · Paper page
- Holgate, 2003, Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling, J. Allergy Clin. Immunol., 111, 18, 10.1067/mai.2003.25 · DOI · Paper page
- Kumar, 2011, High-through screening assays for cyclooxygenase-2 and 5-lipoxygenase, the targets for inflammatory disorders, Ind. J. Biochem. Biophys., 48, 256
- Saklatvala, 2004, The p38 MAP kinase pathway as a therapeutic target in inflammatory disease, Curr. Opin. Pharmacol., 4, 372, 10.1016/j.coph.2004.03.009 · DOI · Paper page
- Yang, 2003, Transcriptional regulation by the MAP kinase signaling cascades, Gene, 320, 3, 10.1016/S0378-1119(03)00816-3 · DOI · Paper page
- Katsube, 2003, Hyaluronidase-inhibiting polysaccharide isolated and purified from hot water extract of sporophyll of Undaria pinnatifida, Food Sci. Technol. Res., 9, 25, 10.3136/fstr.9.25 · DOI
- Elzoghby, A.O., Freag, M.S., and Elkhodairy, K.A. (2018). Biopolymeric nanoparticles for targeted drug delivery to brain tumors. Nanotechnology-Based Targeted Drug Delivery Systems for Brain Tumors, Elsevier. · DOI
- Havale, 2009, Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes, Bioorg. Med. Chem., 17, 1783, 10.1016/j.bmc.2009.01.061 · DOI · Paper page
- Bruhn, 1997, Anticoagulant fucoidan fractions from fucus vesiculosus induce platelet activation in vitro, Thromb. Res., 85, 479, 10.1016/S0049-3848(97)00037-6 · DOI
- Zayed, A., Muffler, K., Hahn, T., Rupp, S., Finkelmeier, D., Burger-Kentischer, A., and Ulber, R. (2016). Physicochemical and biological characterization of fucoidan from Fucus vesiculosus purified by dye affinity chromatography. Mar. Drugs, 14. · DOI
- Lahrsen, 2018, Size-dependent pharmacological activities of differently degraded fucoidan fractions from Fucus vesiculosus, Carbohydr. Polym., 189, 162, 10.1016/j.carbpol.2018.02.035 · DOI
- Jönsson, M., Allahgholi, L., Sardari, R.R., Hreggviðsson, G.O., and Nordberg Karlsson, E. (2020). Extraction and modification of macroalgal polysaccharides for current and next-generation applications. Molecules, 25. · DOI · Paper page
- Luthuli, S., Wu, S., Cheng, Y., Zheng, X., Wu, M., and Tong, H. (2019). Therapeutic effects of fucoidan: A review on recent studies. Mar. Drugs, 17. · DOI · Paper page
- Fletcher, 2017, The seasonal variation of fucoidan within three species of brown macroalgae, Algal Res., 22, 79, 10.1016/j.algal.2016.10.015 · DOI · Paper page
- Seyoum, 2006, Structure–radical scavenging activity relationships of flavonoids, Phytochemistry, 67, 2058, 10.1016/j.phytochem.2006.07.002 · DOI · Paper page
- Lim, 2014, Isolation and antioxidant capacity of fucoidan from selected Malaysian seaweeds, Food Hydrocoll., 42, 280, 10.1016/j.foodhyd.2014.03.007 · DOI · Paper page
- Mussatto, 2014, Chemical composition and antioxidant activity of sulphated polysaccharides extracted from Fucus vesiculosus using different hydrothermal processes, Chem. Pap., 68, 203
- Le, 2007, Identification and quantification of antioxidants in Fructus lycii, Food Chem., 105, 353, 10.1016/j.foodchem.2006.11.063 · DOI · Paper page
- He, J., Xu, Y., Chen, H., and Sun, P. (2016). Extraction, structural characterization, and potential antioxidant activity of the polysaccharides from four seaweeds. Int. J. Mol. Sci., 17. · DOI · Paper page
- Zayed, A., and Ulber, R. (2020). Fucoidans: Downstream processes and recent applications. Mar. Drugs, 18. · DOI
- Yang, 2011, In vitro antioxidant activities of sulfated polysaccharide fractions extracted from Corallina officinalis, Int. J. Biol. Macromol., 49, 1031, 10.1016/j.ijbiomac.2011.08.026 · DOI
- Zayed, 2019, Phenomenological investigation of the cytotoxic activity of fucoidan isolated from Fucus vesiculosus, Process Biochem., 81, 182, 10.1016/j.procbio.2019.03.026 · DOI
- 2019, Influence of molecular weight on the properties of Sargassum muticum fucoidan, Algal Res., 38, 101393, 10.1016/j.algal.2018.101393 · DOI
- Mak, 2013, Fucoidan from New Zealand Undaria pinnatifida: Monthly variations and determination of antioxidant activities, Carbohydr. Polym., 95, 606, 10.1016/j.carbpol.2013.02.047 · DOI · Paper page
- Somasundaram, 2016, Cytotoxic effect of fucoidan extracted from Sargassum cinereum on colon cancer cell line HCT-15, Int. J. Biol. Macromol., 91, 1215, 10.1016/j.ijbiomac.2016.06.084 · DOI
- Wang, 2009, Total phenolic compounds, radical scavenging and metal chelation of extracts from Icelandic seaweeds, Food Chem., 116, 240, 10.1016/j.foodchem.2009.02.041 · DOI · Paper page
- Parys, 2010, In vitro chemopreventive potential of fucophlorethols from the brown alga Fucus vesiculosus L. by anti-oxidant activity and inhibition of selected cytochrome P450 enzymes, Phytochemistry., 71, 221, 10.1016/j.phytochem.2009.10.020 · DOI
- Jouzeau, 1997, Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs, Drugs, 53, 563, 10.2165/00003495-199753040-00003 · DOI · Paper page
- Park, 2011, Anti-inflammatory effects of fucoidan through inhibition of NF-κB, MAPK and Akt activation in lipopolysaccharide-induced BV2 microglia cells, Food Chem. Toxicol., 49, 1745, 10.1016/j.fct.2011.04.020 · DOI · Paper page
- Dewi, 2016, In silico analysis of the potential of the active compounds fucoidan and alginate derived from Sargassum sp. as inhibitors of COX-1 and COX-2, Med Arch., 70, 172, 10.5455/medarh.2016.70.172-176 · DOI
- Lee, 2012, Molecular characteristics and anti-inflammatory activity of the fucoidan extracted from Ecklonia cava, Carbohydr. Polym., 89, 599, 10.1016/j.carbpol.2012.03.056 · DOI · Paper page
- Phull, 2017, In vitro and in vivo evaluation of anti-arthritic, antioxidant efficacy of fucoidan from Undaria pinnatifida (Harvey) Suringar, Int. J. Biol. Macromol., 97, 468, 10.1016/j.ijbiomac.2017.01.051 · DOI
- Lim, 2015, Fucoidan from Fucus vesiculosus protects against alcohol-induced liver damage by modulating inflammatory mediators in mice and HepG2 cells, Mar. Drugs, 13, 1051, 10.3390/md13021051 · DOI
- Rosoiu, 2008, Original bioactive complexes rich in glycosaminoglycans obtained from small fish, Roum. Soc. Biol. Sci., 13, 3944
- Kim, 2010, Fucoidan, a sulfated polysaccharide, inhibits adipogenesis through the mitogen-activated protein kinase pathway in 3T3-L1 preadipocytes, Life Sci., 22, 791, 10.1016/j.lfs.2010.03.010 · DOI
- Sanjeewa, 2017, Anti-inflammatory activity of a sulfated polysaccharide isolated from an enzymatic digest of brown seaweed Sargassum horneri in RAW 264.7 cells, Nutr. Res. Pract., 11, 3, 10.4162/nrp.2017.11.1.3 · DOI · Paper page
- Unnikrishnan, P.S., Suthindhiran, K., and Jayasri, M.A. (2014). Inhibitory potential of Turbinaria ornata against key metabolic enzymes linked to diabetes. BioMed Res. Int. · DOI
- Unnikrishnan, 2015, Antidiabetic potential of marine algae by inhibiting key metabolic enzymes, Front. Life Sci., 8, 148, 10.1080/21553769.2015.1005244 · DOI
- Wheeler, 2016, The intrinsic pathway of coagulation as a target for antithrombotic therapy, Hematol. Oncol. Clin. North Am., 30, 1099, 10.1016/j.hoc.2016.05.007 · doi:10.1016/j.hoc.2016.05.007
- Chen, 2015, Sulfated polysaccharides isolated from cloned Grateloupia filicina and their anticoagulant activity, BioMed Res. Int., 2015, 612352
- Athukorala, 2008, Evaluation of biomolecular interactions of sulfated polysaccharide isolated from Grateloupia filicina on blood coagulation factors, J. Microbiol. Biotechnol., 18, 503
- Zhang, 2015, Screening of complex fucoidans from four brown algae species as procoagulant agents, Carbohydr. Polym., 115, 677, 10.1016/j.carbpol.2014.09.001 · DOI
- Obluchinsksya, 2015, Effects of ultrasound treatment on the chemical composition and anticoagulant properties of dry Fucus extract, Pharm. Chem. J., 49, 183, 10.1007/s11094-015-1250-8 · DOI
- Thanh, 2013, Structure of fucoidan from brown seaweed Turbinaria ornata as studied by electrospray ionization mass spectrometry (ESIMS) and small angle X-ray scattering (SAXS) techniques, Mar. Drugs, 11, 2431, 10.3390/md11072431 · DOI
- Imbs, 2015, Antioxidant activity of fucose-containing sulfated polysaccharides obtained from Fucus evanescens by different extraction methods, J. Appl. Phycol., 27, 545, 10.1007/s10811-014-0293-7 · DOI
- Akbarov, 2020, Metabolite profiling and mechanisms of bioactivity of snake autolysate—A traditional Uzbek medicine, J. Ethnopharmacol., 250, 112459, 10.1016/j.jep.2019.112459 · doi:10.1016/j.jep.2019.112459
- Anderson, 1976, Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel filtration, Thromb. Res., 9, 575, 10.1016/0049-3848(76)90105-5 · DOI · Paper page
- Quick, 1940, The clinical application of the hippuric acid and the prothrombin tests, Am. J. Clin. Pathol., 10, 222, 10.1093/ajcp/10.3.222 · DOI · Paper page
- Denson, 1973, The measurement of heparin: A method based on the potentiation of anti-factor Xa, Thromb. Haemost., 30, 471, 10.1055/s-0038-1649125 · DOI
- Wang, J.Z., Zhang, R.Y., and Bai, J. (2020). An anti-oxidative therapy for ameliorating cardiac injuries of critically ill COVID-19-infected patients. Int. J. Cardiol. · DOI
- Thachil, J., Tang, N., Gando, S., Falanga, A., Cattaneo, M., Levi, M., Clarck, C., and Iba, T. (2020). ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J. Thromb. Haemost. · DOI · Paper page
Cited by
Phytochemical and Potential Properties of Seaweeds and Their Recent Applications: A Review
El-Beltagi, H. S., Mohamed, A. A., Mohamed, H. I., Ramadan, K. M. A., Barqawi, A. A., & Mansour, A. T. (2022) · Marine Drugs · doi:10.3390/md20060342 · Cited by 354
Immunomodulatory and Anti-Inflammatory Effects of Fucoidan: A Review
Apostolova, E., Lukova, P., Baldzhieva, A., Katsarov, P., Nikolova, M., Iliev, I., Peychev, L., Trica, B., Oancea, F., Delattre, C., et al. (2020) · Polymers · doi:10.3390/polym12102338 · Cited by 345
A Review on Fucoidan Structure, Extraction Techniques, and Its Role as an Immunomodulatory Agent
Jayawardena, T. U., Nagahawatta, D. P., Fernando, I. P. S., Kim, Y.-T., Kim, J.-S., Kim, W.-S., Lee, J. S., & Jeon, Y.-J. (2022) · Marine Drugs · doi:10.3390/md20120755 · Cited by 149
Fucoidan in pharmaceutical formulations: A comprehensive review for smart drug delivery systems
Haggag, Y., Abd Elrahman, A., Ulber, R., & Zayed, A. (2023) · Marine Drugs · doi:10.3390/md21020112 · Cited by 126
In Vitro Anti-Inflammatory Activities of Fucoidans from Five Species of Brown Seaweeds
Obluchinskaya, E. D., Pozharitskaya, O. N., & Shikov, A. N. (2022) · Marine Drugs · doi:10.3390/md20100606 · Cited by 113
Self-citation
Metadata
- Authors
- Pozharitskaya, O. N., Obluchinskaya, E. D., & Shikov, A. N.
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2020-05-22
- Volume
- 18
- Issue
- 5
- Pages
- 275
- ISSN
- 1660-3397 (ISSN-L)
- OpenAlex
- W3026787770
- Cited by
- 197
- References
- 12
- FWCI
- 19.34
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- State Task of MMBI KSC RAS, Ministry of Education and Science of the RF (01201453843)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mechanisms of Bioactivities of Fucoidan from the Brown Seaweed Fucus vesiculosus L. of the Barents Sea. https://app.cochat.ai/papers/10.3390/md18050275
- The paper
- Pozharitskaya, O. N., Obluchinskaya, E. D., & Shikov, A. N. (2020). Mechanisms of Bioactivities of Fucoidan from the Brown Seaweed Fucus vesiculosus L. of the Barents Sea. Marine Drugs. https://doi.org/10.3390/md18050275
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.